XML 20 R7.htm IDEA: XBRL DOCUMENT v3.23.1
UNAUDITED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Millions
Total
Cumulative Effect of Adoption of Accounting Standards Update
Common Stock
Treasury Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect of Adoption of Accounting Standards Update
Retained Earnings
Retained Earnings
Cumulative Effect of Adoption of Accounting Standards Update
Accumulated Other Comprehensive Loss
Balance (in shares) at Dec. 31, 2021     63,584 (22,518)          
Balance at Dec. 31, 2021 $ 6,178 $ (66) $ 0 $ (24,290) $ 6,159 $ (96) $ 24,453 $ 30 $ (144)
Increase (Decrease) in Stockholders' Equity                  
Net income (loss) (700)           (700)    
Foreign currency translation adjustments, net of tax (38)               (38)
Net unrealized gains on available-for-sale securities, net of tax (1)               (1)
Exercise of stock options and vesting of restricted stock units and performance share units (in shares)     175            
Exercise of stock options and vesting of restricted stock units and performance share units $ 3   $ 0   3        
Repurchase of common stock (in shares) (487)     (487)          
Repurchase of common stock $ (1,100)     $ (1,100)          
Stock-based compensation and other stock-based payments 97       97        
Balance (in shares) at Mar. 31, 2022     63,759 (23,005)          
Balance at Mar. 31, 2022 4,373   $ 0 $ (25,390) 6,163   23,783   (183)
Balance (in shares) at Dec. 31, 2022     63,781 (25,918)          
Balance at Dec. 31, 2022 2,782   $ 0 $ (30,983) 6,491   27,541   (267)
Increase (Decrease) in Stockholders' Equity                  
Net income (loss) 266           266    
Foreign currency translation adjustments, net of tax (2)               (2)
Net unrealized gains on available-for-sale securities, net of tax 2               2
Exercise of stock options and vesting of restricted stock units and performance share units (in shares)     227            
Exercise of stock options and vesting of restricted stock units and performance share units $ 105   $ 0   105        
Repurchase of common stock (in shares) (878)     (878)          
Repurchase of common stock $ (2,195)   $ 0 $ (2,195)          
Stock-based compensation and other stock-based payments 116       116        
Balance (in shares) at Mar. 31, 2023     64,008 (26,796)          
Balance at Mar. 31, 2023 $ 1,074   $ 0 $ (33,178) $ 6,712   $ 27,807   $ (267)